Accès à distance ? S'identifier sur le proxy UCLouvain
Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial.
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès interdit |
Publication date | 2017 |
Language | Anglais |
Journal information | "American Journal of Kidney Diseases" - Vol. 69, no. 2, p. 210-219 (2017) |
Peer reviewed | yes |
Publisher | W.B.Saunders Co. ((United States) Philadelphia, PA) |
issn | 0272-6386 |
e-issn | 1523-6838 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/NEFR - Pôle de Néphrologie UCL - (SLuc) Service de néphrologie |
Keywords | Autosomal dominant polycystic kidney disease (ADPKD) ; TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3:4 ; acute kidney pain event ; analgesic ; pain ; pain severity ; tolvaptan ; vasopressin |
Links |
Bibliographic reference | Casteleijn, Niek F ; Blais, Jaime D ; Chapman, Arlene B ; Czerwiec, Frank S ; Devuyst, Olivier ; et. al. Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial.. In: American Journal of Kidney Diseases, Vol. 69, no. 2, p. 210-219 (2017) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/178257 |